Literature DB >> 24193405

Mg²⁺ modulation of the single-channel properties of KCa3.1 in human erythroleukemia cells.

Colin J Stoneking1, Michael J Mason.   

Abstract

The activity of many ion channels is modulated by ions other than the ones they primarily conduct, with important consequences for cell signalling. In this study, we demonstrate that Mg(2+) inhibits the intermediate conductance calcium-activated potassium channel (KCa3.1) in human erythroleukemia cells via two distinct mechanisms. Firstly, intracellular Mg(2+) blocks this channel via a rapid, voltage-dependent mechanism that leads to a reduction of the channel's unitary current. We show that this block involves interactions which are well described by the Woodhull model. Secondly, we found that Mg(2+) reduces the open probability of the channel. By analysing the channel kinetics, we found that this reduction in open probability is at least partly due to a reduction in the rate of channel opening from the closed state, a finding that can be accounted for if Mg(2+) competes with Ca(2+) for the activation site. Consistent with this interpretation, we find that the decline in relative NPo observed in the presence of 5 mM Mg(2+) could be significantly reduced by increasing the free Ca(2+) concentration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193405     DOI: 10.1007/s00424-013-1375-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  31 in total

Review 1.  Regulation of magnesium homeostasis and transport in mammalian cells.

Authors:  Andrea Romani
Journal:  Arch Biochem Biophys       Date:  2006-08-07       Impact factor: 4.013

Review 2.  International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels.

Authors:  Aguan D Wei; George A Gutman; Richard Aldrich; K George Chandy; Stephan Grissmer; Heike Wulff
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

3.  Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Authors:  Kenneth I Ataga; Wally R Smith; Laura M De Castro; Paul Swerdlow; Yogen Saunthararajah; Oswaldo Castro; Elliot Vichinsky; Abdullah Kutlar; Eugene P Orringer; Greg C Rigdon; Jonathan W Stocker
Journal:  Blood       Date:  2008-01-11       Impact factor: 22.113

4.  Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.

Authors:  Colin J Stoneking; Oshini Shivakumar; David Nicholson Thomas; William H Colledge; Michael J Mason
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-13       Impact factor: 4.249

5.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.

Authors:  P Martin; T Papayannopoulou
Journal:  Science       Date:  1982-06-11       Impact factor: 47.728

6.  All-or-none response of the Ca2+-dependent K+ channel in inside-out vesicles.

Authors:  J García-Sancho; A Sanchez; B Herreros
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

7.  Separation of gating properties from permeation and block in mslo large conductance Ca-activated K+ channels.

Authors:  D H Cox; J Cui; R W Aldrich
Journal:  J Gen Physiol       Date:  1997-05       Impact factor: 4.086

Review 8.  Regulation of cellular magnesium.

Authors:  A M Romani; A Scarpa
Journal:  Front Biosci       Date:  2000-08-01

9.  Interaction of internal Ba2+ with a cloned Ca(2+)-dependent K+ (hslo) channel from smooth muscle.

Authors:  F Diaz; M Wallner; E Stefani; L Toro; R Latorre
Journal:  J Gen Physiol       Date:  1996-03       Impact factor: 4.086

10.  Distinct metal ion binding sites on Ca(2+)-activated K+ channels in inside-out patches of human erythrocytes.

Authors:  T Leinders; R G van Kleef; H P Vijverberg
Journal:  Biochim Biophys Acta       Date:  1992-11-23
View more
  1 in total

1.  Kefir induces apoptosis and inhibits cell proliferation in human acute erythroleukemia.

Authors:  Fatemeh Jalali; Mohammadreza Sharifi; Rasoul Salehi
Journal:  Med Oncol       Date:  2015-12-26       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.